Why Are Ionis Pharmaceuticals Shares Tanking Today?

Pfizer Inc PFE and Ionis Pharmaceuticals Inc IONS will discontinue the Pfizer-led clinical development program for vupanorsen (PF-07285557), an investigational antisense therapy.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: BiotechNewsHealth CareContractsMoversTrading IdeasGeneralBriefswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!